Mavoglurant
Mavoglurant developmental code name AFQ-056 is an experimental drug candidate for the treatment of fragile X syndrome. Reference standards of Mavoglurant API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Mavoglurant
[catalogue_number] => PA 13 3110000
[category_ids] => ,79,71,78,70,82,75,
[chemical_name] =>
[weight] => 313.4
[form] => C19H23NO3
[cas] => 543906-09-8
[pslug] => 543906-09-8-mavoglurant-api-standards-pa133110000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
